Mattia Schipani

机构：Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Azienda Ospedaliero Universitaria Maggiore della Carita · ORCID：0009-0009-5710-2781

发表论文 19 篇 · 总被引 296 次 · h-index 8

代表论文

• KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study (2019 · Haematologica · 被引 139)
• Precision Medicine Management of Chronic Lymphocytic Leukemia (2020 · Cancers · 被引 39)
• Clonally unrelated Richter syndrome are truly de novo diffuse large B‐cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome (2022 · British Journal of Haematology · 被引 24)
• Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY (2023 · EClinicalMedicine · 被引 21)
• Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels (2025 · Blood Advances · 被引 19)
• ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings (2022 · Leukemia & lymphoma/Leukemia and lymphoma · 被引 10)